Early introduction of selective immunosuppressive therapy associated with favorable clinical outcomes in patients with immune checkpoint inhibitor

Early introduction of selective immunosuppressive therapy associated with favorable clinical outcomes in patients with immune checkpoint inhibitor–induced colitis

Published:2019-04-02 Issue:1 Volume:7 Page:
ISSN:2051-1426
Container-title:Journal for ImmunoTherapy of Cancer
language:en
Short-container-title:j. immunotherapy cancer

Author:

Abu-Sbeih Hamzah,Ali Faisal S.,Wang Xuemei,Mallepally Niharika,Chen Ellie,Altan Mehmet,Bresalier Robert S.,Charabaty Aline,Dadu Ramona,Jazaeri Amir,Lashner Bret,Wang Yinghong^ORCID

Publisher

BMJ

Subject

Cancer Research,Pharmacology,Oncology,Molecular Medicine,Immunology,Immunology and Allergy

Link

http://link.springer.com/content/pdf/10.1186/s40425-019-0577-1.pdf

Reference34 articles.

1. Brahmer JR, Lacchetti C, Schneider BJ, et al. Management of immune-related adverse events in patients treated with immune checkpoint inhibitor therapy: American society of clinical oncology clinical practice guideline. J Clin Oncol. 2018;36(17):1714–68.

2. Puzanov I, Diab A, Abdallah K, et al. Managing toxicities associated with immune checkpoint inhibitors: consensus recommendations from the society for immunotherapy of cancer (sitc) toxicity management working group. J Immunother Cancer. 2017;5:95.

3. Thompson JA. New nccn guidelines: recognition and management of immunotherapy-related toxicity. J Natl Compr Cancer Netw. 2018;16:594–6.

4. Haanen J, Carbonnel F, Robert C, et al. Management of toxicities from immunotherapy: Esmo clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2017;28:iv119–iv42.

5. Tian Y, Abu-Sbeih H, Wang Y. Immune checkpoint inhibitors-induced colitis. Adv Exp Med Biol. 2018;995:151–7.

Cited by 144 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immune checkpoint inhibitors rechallenge in non-small cell lung cancer: Current evidence and future directions;Cancer Letters;2024-11

2. Peripheral nervous system immune-related adverse events due to checkpoint inhibition;Nature Reviews Neurology;2024-08-09

3. Novel endoscopic scoring system for immune mediated colitis: a multicenter retrospective study of 674 patients;Gastrointestinal Endoscopy;2024-08

4. A 1-year follow-up study on checkpoint inhibitor-induced colitis: results from a European consortium;ESMO Open;2024-07

5. Management of immune check-point inhibitor-associated colitis in patients with advanced metastatic cancers: A review article;Journal of Family Medicine and Primary Care;2024-06-28